Saturday 26 October 2013

Movember's new branding for 2013 event

The Movember men’s health initiative has launched new branding for this year’s event.





Movember encourages men to grow moustaches during November to raise awareness of, and funds for, prostate and testicular cancer.

The branding, which is refreshed each year, is created by Melbourne-based consultancy Urchin Associates.




Last year’s look was based on the idea of a traditional father-and-son run business; while this year’s branding has a monochrome palette, with a rebellious aesthetic based on a campaign message ‘if you don’t like our moustaches we don’t like your laws’.



The main Movember word-mark has a hand-drawn brushstroke look, and is always capitalised; while secondary text uses capitalised stencil-like typography.




Snake and wolf graphics are used across the branding, with a two-headed snake forming a line above the logo on a number of applications and a howling wolf seen with lightening flashes.


Thursday 24 October 2013

Movember-bits and bobs

The Mr Mo book can be bought from Amazon, while there are more details about Movemeber here. Metro is also giving away 100 limited-edition printed copies of the new book. For a chance to win one, go to metro.co.uk/madeforthecity

GENERAL,UROLOGY and CHARITY WEBSITES (Updated-24th October 2013)

This is a copy of useful websites found in the main information pages under April 2009....
Posted again to remind me to add/remove any as required and update said April 2009 pages too! (added CANSA-South Africa)

GENERAL/UROLOGY MEDICAL
WEBSITES


CANSA-South Africa
OncLive
PULSE-General Medical Information/News
Prostate Conditions Education Council (PCEC)-USA
British Association of Urological Nurses(BAUN)
EUROCARE
URO TODAY
UROLOGY TIMES
American Urological Association
EUROPEAN ASSOCIATION OF UROLOGY
NHS-CHOICES
NICE-INDEPENDENT ADVISORY GROUP (UK)
PATIENT UK
MEDICAL NEWS TODAY (UK with global news)
Scottish Practice Nurses Association
MEDICAL DAILY
University of Florida Shands Cancer Center
European Hospital


UROLOGY,CANCER AND PROSTATE
CANCER SPECIFIC CHARITY WEBSITES


UK
The Urology Foundation (UK)
The Graham Fulford Charitable Trust (UK)
Friends of Prostate Sufferers (FOPS) (UK)
PCaSO-Prostate Cancer Network (UK)
Prostaid (UK)
UCARE-UK
THE PROSTATE SCREENING TRUST
PROSTATE SCOTLAND
BRISTOL UROLOGICAL INSTITUTE
PROSTATE CANCER UK
Prostate Cancer UK-Youtube Channel
PROSTATE CANCER SUPPORT ASSOCIATION (UK)
CANCER RESEARCH UK
CANCERBACKUP/MACMILLAN (UK)
The Cystitis and Overactive Bladder Foundation (UK)
The Bladder and Bowel Foundation (UK)
The X Foundation (Raising money for the Prostate Cancer Research Foundation"

ROW
Prostate Cancer InfoLink
The Prostate Cancer Foundation of Australia
The Cancer Society of New Zealand
The Prostate Cancer Foundation-USA
American Cancer Society
Canadian Prostate Cancer Network
CANADIAN CANCER SOCIETY
WORLD CANCER RESEARCH FUND
ZERO (USA)

Tuesday 22 October 2013

Canada-PCC New Recommendations

4th September 2013

TORONTO:  New recommendations released today by Prostate Cancer Canada (PCC) will empower Canadian males to take a more active role in monitoring their number one cancer risk: prostate cancer. A recent nationwide poll showed that while 87% of Canadian men aged 35+ fear prostate cancer, less than half anticipate being tested in the next 12 months – even though early diagnosis can increase the odds of survival.

“Prostate Cancer Canada recognizes that men need to be better informed about prostate testing, particularly the Prostate Specific Antigen (PSA) blood test,” says Dr. Stuart Edmonds, VP, Research, Health Promotion & Survivorship, Prostate Cancer Canada. “To address this confusion, we conducted an extensive review of the evidence and from this developed our primary recommendation: Men should get a baseline PSA test in their 40s instead of waiting until their 50s.”

“PSA levels can vary between individuals so a test in the early 40’s can provide a baseline and allow us to better tailor clinical follow-up,” says Prostate Cancer Canada spokesperson Dr. Rajiv Singal, Urologist at Toronto East General Hospital and Assistant Professor at the University of Toronto. “The PSA is an important marker for a disease in which symptoms are not always present.”

PCC also recommends the decision to end PSA testing should be based on individual risk, rather than an arbitrary cut-off such as age 70. “Men are living longer and their lives should not be cut short or diminished by prostate cancer,” says Dr. Edmonds. “The decision to end testing should be a shared decision determined by a man and his primary care provider.”

“Some men are at increased risk because of ethnicity (Black African or Black Caribbean descent), a family history of prostate cancer, or age,” says Dr. Singal. “Men at high risk should talk to their primary care provider even earlier than their 40s. However, in my 18 years of practice, the majority of aggressive cancers have been found in men with seemingly no risk factors – underscoring the importance of baseline testing.”
More from link below

Monday 21 October 2013

Australia-Prostate Cancer Pack




Please remember the following is from the Prostate Cancer Foundation of Australia but may be
of general interest globally.

Prostate Cancer Foundation of Australia's Localised Prostate Cancer Patient Pack is designed for people with a recent diagnosis of localised prostate cancer. The pack contains a suite of information resources for men and their families and friends.

http://www.prostate.org.au/articleLive/pages/Localised-Prostate-Cancer-Pack.html

UK-PSAwatch In Action!

VIDEOS: Lifesaving Winsford cancer testing event is a UK first

Wednesday 16th October 2013


The testing team at Asda in Winsford

Veteran LHPCSG fundraiser, Winn Bond, process the test in less than ten minutes.

SHOPPERS in Winsford were given the offer of a lifetime courtesy of a royally-recognised cancer testing pioneer.
For the first time ever in the UK, men had the chance to get a lifesaving prostate specific antigen (PSA) test carried out for free while they picked up their weekly groceries.

  The Leighton Hospital Prostate Cancer Support Group (LHPCSG) has tested 1,210 men this year alone – successfully treating 38 men for cancer. The charity’s chairman, Gary Steele, was awarded the MBE this year for his lifesaving work, and his tireless campaign to get the Government to roll out his technique across the NHS.

“It’s gone very, very well. There has been a great turnout,” said the Cherry Crescent resident of teh event on Monday, October 7. “Men are coming along, sitting down, and putting their test into the machine. That’s him finished then, and he can go shopping with his misses. “Ten minutes later, he can come back and he’s got his result.

 It’s completely revolutionised how we can operate.” The supermarket-based event allowed Gary to target men who might not have found time to attend one of the dedicated testing events he runs throughout the year.

  Tony Vine, 68, was visiting his Winsford partner from his home in Rossett in North Wales when he dropped into Asda. In less than 10 minutes he was able to get a PSA test and put his mind at rest. “It was an absolute piece of cake, no problems whatsoever. “I’ve been saying I’d get it done for several years but never got round to it. “It was fantastic walking in today and being able to get it done so quickly.”

  http://www.winsfordguardian.co.uk/video/2748009416001/?ref=vidshare

If the PSA test result shows a risk of developing cancer, the charity’s eurologist, Dr David Baxter Smith, conducts another simple test that avoids the need for an invasive biopsy procedure. The sample is then boxed and sent to experts in Cambridge, costing the charity £200.

LHPSSG’s lifesaving work has cost in excess of £40,000 this year alone – all of which has to be raised by charitable donation. “It’s a lot of money, but what price do you put on a man’s life?” said Gary.

http://www.winsfordguardian.co.uk/video/2748009421001/?ref=vidshare

Gary is encouraging men to ‘save a dad; grow a moustache’ next month for ‘Movember’ and raise money for the LHPSSG.

To get in touch for a PSA test or for fundraising forms, call 01606 553097 or email coli.hubball@tiscali.co.uk

 For more on prostate cancer, visit prostatecanceruk.org Breakout The UK falls well behind the rest of Europe, and America, in PSA testing. Gary’s work massively expands the current treatments available on the NHS – offering PSA testing to a wider age range, with the offer of further expert testing if required.

In the rest of Europe and throughout many countries elsewhere in the world, all men of 50 are required to undertake a test, and Gary wants to see the UK follow the example, as well as wider use of the life-extending prostate cancer drug, abiraterone.

LHPSSG has detected 51 cancers this year alone, of which 38 have been successfully treated – that’s 38 lives saved. The remainder are on active surveillance, whereby Gary’s charity keeps tabs on the patient, offering further testing and continued support.

80 per cent of men diagnosed with prostate cancer don’t have any symptoms.

 

UK-New stat for Black men cancer risk

One in four Black men in UK will get prostate cancer


A shocking new figure released in Black History Month by the health charity Prostate Cancer UK reveals that one in every four Black men in the UK will be diagnosed with prostate cancer at some point in his lifetime*. That’s double the overall 1-in-8 cradle-to-grave risk faced by all men in the UK.

“It’s like Russian Roulette but with only four players chancing the bullet. This statistic is a wake-up call to Black men about the unique danger they face - and we’re warning them to act on it. Fathers, brothers, partners, sons - with every fourth Black man or boy in the UK destined to get this potentially fatal disease at some time, it’s vital that everything possible is done to identify and catch aggressive cancers early”, said Cordwell Thomas, who heads Prostate Cancer UK’s partnership with Britain’s African and African Caribbean communities.

Calculation of the specific lifetime risk to Black men was undertaken by Prostate Cancer UK as part of its continuing drive to support the men of Britain’s two million strong African and African Caribbean population in recognising both the threat to their prostate health and their responsibility to be proactive in seeking out advice and support.

Cordwell Thomas continued:

“Many health professionals are not even aware that Black ancestry is a prostate cancer risk factor. What’s more, Black guys often don’t claim their rights to health care. They’re not first in line to see the GP or to call our helpline to discuss concerns like erectile dysfunction or problems peeing. With so many lives at risk, we all have to work together to ensure that Black men wise up to the issue and those affected seek and receive appropriate healthcare.”

With the backing of its major funding partner, Movember, Prostate Cancer UK provides support to thousands of men facing prostate cancer and it has consistently emphasised the higher risk faced by Black men. The urgent need to help Britain’s Black communities act upon their raised risk means Prostate Cancer UK is bringing together the community leaders and clinicians who can encourage Black men to face up to their heightened prostate cancer risk, engage with it, and take the necessary action.

“It’s your life and the message is know your risk and know your responsibility. It’s about taking charge of your own health. As a Black man, you’re already in a high risk group, so the worst thing to do is to ignore the risk. Confront it, speak to your wife, partner or friends about it, and consult your GP over whether a test is advisable in your case. Even when you have no actual symptoms, you are entitled to a test if you are over 50 and have spoken to your GP”, says Cordwell Thomas.

Football legend, sports broadcaster and ambassador for Prostate Cancer UK, Mark Bright said:

“I’m a black man and I am over 50. My risk of being diagnosed with prostate cancer is significantly higher than that of a white man of the same age.  Now we know that one in four black men will be diagnosed with prostate cancer at some time in his life, we owe it to ourselves and our loved ones to take responsibility for our health and understand our risks.

“If you’re a black man and over 50, speak to your GP or call the Prostate Cancer UK helpline  to find out about your risk and what you can do about it.”

Prostate Cancer UK volunteer Phil Kissi MBE is a survivor of the disease:

“It is terrifying to think that I could so easily have carried on without knowing anything about prostate cancer despite it being the most common cancer diagnosed in men in the UK. Luckily my GP was very supportive when I raised my concerns with him and I caught the cancer in time to have successful treatment but it saddens me to think that others may not have this chance.
“Ultimately it is up to us men to respect and take responsibility for our health but I needed a lot of support from my friends and family,” he says.

“2013 is the 65th anniversary of the Windrush Landing. It is ironical that youngsters who arrived on that ship a whole lifetime ago and have won countless battles over the decades still face a major public health inequality based on nothing but ethnicity. That’s why Prostate Cancer UK puts in the research, services and support that will help more Black men like Phil to survive this disease,” said Cordwell Thomas.

If you have concerns about prostate cancer or the raised risk to men of black ancestry please call Prostate Cancer UK's confidential Helpline on 0800 074 8383 or visit www.prostatecanceruk.org. The helpline is free to landlines, staffed by specialist nurses, and open from 9am to 6pm Monday to Friday with late opening until 8pm on Wednesdays.

Saturday 19 October 2013

Initial Approach from Laborie Medical


Oct 18 (Reuters) - Mediwatch PLC : * Response to increase in share price * Mediwatch confirms that it has received an initial approach from laborie




Monday 14 October 2013

Mediwatch-Newsletter 2013 Q3

Mediwatch Newsletter 2013 Q3

LATEST NEWS AND FUTURE EVENTS





Latest News/Website Updates


Oct 18 (Reuters) - Mediwatch PLC : * Response to increase in share price * Mediwatch confirms that it has received an initial approach from laborie






Mediwatch Positions/Jobs

Future Events Events where Mediwatch are attending/exhibiting will be marked as so or updated,hopefully before the event is finished.More Events to add later

University of Minnesota Colon & Rectal surgery meeting in Minneapolis to demonstrate our newest products.(Wednesday | Oct 23, 2013-date is a guess! )

AUGS 34th Annual Scientific Meeting

October 16-19, 2013
Location: Caesars Palace, Las Vegas, NV

2013 Annual Conference
October 11-14, 2013
Hyatt Regency
Chicago, IL



 Mediwatch/Distributor Training Courses

Urodynamics Workshop WPB--- 23,24 Mar 2013
ARM Workshop Boston 31 May 2013
Urodynamics Workshop WPB 9,10 Nov 2013
 

Newsletters
Mediwatch Newsletter 2013 Q3
Mediwatch Newsletter 2013 Q2
Mediwatch Newsletter 2012 Q1
Mediwatch Newsletter 2011 Q4

STUFF THAT MAYBE DID BUT NOW DOESN'T FIT IN WITH THE TITLE...